It's not a change of blood. Human blood is made up of cells. You should be talking about DC-CIK, NK, CD3AK, γδ T and other cells in CLS-MCT multicellular immunotherapy in biotechnology. These cells can kill tumor cells, inhibit the growth, metastasis and recurrence of tumors, control the metastasis and recurrence of cancer cells after surgery, and enhance the immunity of patients, thus improving their quality of life and prolonging their survival time. Please pay attention to the press conference of CLS-MCT multi-cell immunotherapy technology!